Daily ideas

Lloyds' Q2 2026 net interest income rose 4% to £3.71bn on a 3.22% margin; Q3 results test whether structural hedge income keeps beating mortgage and deposit pressure.

Las Vegas Sands' Q2 2026 property EBITDA fell 16.1% to $1.12 billion as Macao costs rose 18%; Q3 results test whether Macao volume gains turn back into profit.

PACCAR earned $1.43 per share on $7.55 billion of Q2 2026 revenue as gross margin rose to about 14.4%; Q3 tests whether about 42,000 deliveries keep margin at 14.4%-14.5%.

Qualcomm's handset chip revenue fell 20% to $5.09 billion in the June quarter as memory shortages hit Android builds; Q4 results test whether Android recovery offsets lost Apple modem share.

Omnicom grew core revenue 6.1% organically to $5.995 billion in Q2 2026 with a 17.8% core margin; Q3 tests whether media can stay at double digits after losing PepsiCo.

NXP posted record Q2 2026 revenue of $3.50 billion, up 19%, with a 58.0% non-GAAP gross margin; Q3 tests whether 12% auto growth reflects chip content or customer restocking.

AEP earned $1.36 operating EPS in Q2 2026 but raised 2026 guidance to $6.25-$6.55; Q3 tests whether data center sales growth and new rates can outpace higher costs.

O'Reilly grew Q2 2026 sales 8% to $4.89 billion on a 6.0% comp gain; Q3 tests whether double-digit pro growth holds as the tariff price lift fades to about 2%.

Toyota grew quarterly revenue 10.4% to ¥13.53 trillion but operating income fell 8.8% to ¥1.06 trillion; Q2 tests whether North America stays profitable under U.S. tariffs.

Synchrony's Q2 2026 purchase volume rose 8.1% to $49.8 billion while loans grew only 2.4%; Q3 results must show whether new programs like OnePay turn that spending into balances.

Kinder Morgan grew Q2 2026 adjusted EBITDA 12% to $2.2 billion with leverage at 3.6x; Q3 tests whether gas pipeline growth holds without winter-storm and volatility gains.

CPKC grew Q2 2026 revenue 13% to C$4.16 billion while its core operating ratio worsened to 61.6%; Q3 tests whether grain volumes can outrun the coal decline.

Pfizer earned $0.77 adjusted EPS on $15.03 billion of Q2 2026 revenue; Q3 tests whether fall COVID sales of at least $1.3 billion keep its $4 billion outlook intact.

Sanofi grew Q2 2026 sales 17.8% at CER to €11.6 billion as Dupixent topped €5 billion; Q3 tests whether Dupixent sales and margins hold without one-offs.

Howmet grew Q2 2026 revenue 24% to $2.55 billion at a 32.1% adjusted EBITDA margin; Q3 tests whether Engine Products can hold its 37.7% margin while adding staff fast.

Huntington's Q2 2026 net interest margin slipped to 3.21% as deposit costs rose to 1.88%; Q3 results test whether Cadence deposit repricing lifts the margin off its trough.

Teledyne posted record Q2 2026 sales of $1.66 billion, up 9.8%, with backlog at $5.18 billion; Q3 tests whether imaging margins hold above 24% as tariff refunds fade.

Nucor earned $5.04 a share in Q2 2026 on record 7.1 million-ton mill shipments; Q3 tests whether higher steel prices can replace a $130 million one-time raw-material refund.

ICE posted Q2 2026 net revenue of $2.67 billion, up 5%, with a 61% adjusted operating margin; Q3 tests whether 31% higher futures volume turns into revenue at existing fees.